-
Breast Cancer Targeted Therapies and Guidelines, Part 2
03 Jun 2025 00:55 GMT
… in breast cancer treatment.
Breast Cancer Targeted … breast cancer, especially in HR-positive breast cancer and HER2-positive breast cancer … NCCN is the National Comprehensive Cancer Network.
References:
The … HER2-positive breast cancers, adjuvant trastuzumab …
-
Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
01 Jun 2025 12:10 GMT
…
HR-positive breast cancer
Breast cancer is the … Estrogen receptor positive breast cancers have patient specific … 5):821-30.
National Comprehensive Cancer Network. Clinical Practice Guidelines … hormone receptor‑positive breast cancer. Breast Cancer Res. 2021; …
-
Rapid Review Quiz: Ovarian Cancer Screening and Prevention
04 Jun 2025 15:08 GMT
… patients. As noted in the National Comprehensive Cancer Network (NCCN) guidelines, landmark clinical trials … male relatives who have had breast cancer, early-onset cancers, or known …
-
Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
30 May 2025 13:29 GMT
… or metastatic lobular breast cancer. GE HealthCare’ … ER+) breast cancer metastases, including lobular breast cancer. The … breast cancer in the U.S., accounting for 10-15% of all breast cancers … imaging.
The National Comprehensive Cancer Network (NCCN®) is …
-
ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors
23 May 2025 12:41 GMT
… metastatic triple-negative breast cancer do not receive … approved indications per the National Comprehensive Cancer Network® (NCCN®) Clinical … 15% of all breast cancers. TNBC disproportionately impacts … metastatic triple-negative breast cancer), the most common …
-
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
22 May 2025 21:29 GMT
… receptor-positive (HR+) breast cancer,” said Jennifer Schneiders … breast cancer.2*
About the Breast Cancer Index Test
The Breast Cancer …
For the Breast Cancer Index Intended … ®) for Breast Cancer V.4.2025. © National Comprehensive Cancer Network, Inc. …
-
Pre-Treatment Baseline Screening for Breast Cancer–Related Lymphedema
02 May 2025 15:59 GMT
… conducted before breast cancer treatment increased the chance of identifying breast cancer-related lymphedema … monitoring.
Furthermore, the National Comprehensive Cancer Network (NCCN) updated its Breast Cancer Clinical Practice Guidelines recently …
-
The Critical Role of Early Detection in Managing Lymphedema: A Call for Pre-Treatment Baseline Screening for Breast Cancer-related Lymphedema
01 May 2025 20:26 GMT
… Patients for Breast Cancer–Related Lymphedema,… performed prior to breast cancer treatment increased … The National Comprehensive Cancer Network (NCCN) recently updated its Breast Cancer Clinical … baseline-screening-for-breast-cancer-related-lymphedema- …
-
NCCN Flash Update: Changes to NCCN Guidelines for Breast Cancer Version 4.2025
30 Apr 2025 23:32 GMT
… evidence and evolving standards in breast cancer care. These revisions have … to maintaining best practices in breast cancer pharmacotherapy and supporting high- … Updated for Colon Cancer. Email. National Comprehensive Cancer Network. April 30, 2025. Accessed …
-
88 Eflapegrastim, a Long-Acting Granulocyte Colony–Stimulating Factor, Administered the Same Day as Chemotherapy in Patients With Early-Stage Breast Cancer: Results From a Multicenter, Open-Label Study
24 Apr 2025 20:42 GMT
…
Patients with early-stage breast cancer receiving docetaxel and cyclophosphamide … and febrile neutropenia. The National Comprehensive Cancer Network recommends GCSF to reduce the … related complications in early-stage breast cancer. The AEs observed were …
About
© 1995-2025